Key result
IJV access for leadless pacemakers achieves 100% success with no late complications.
Why the study?
Prior reports of internal jugular vein access for leadless pacemaker implantation were primarily small series limited to ventricular devices.
Is internal jugular vein access safe and effective for atrial and ventricular leadless pacemaker implantation?
Observational (n=32)
Yes
Is internal jugular vein access safe and effective for atrial and ventricular leadless pacemaker implantation?
Internal jugular vein access is a safe and effective alternative to femoral vein access for both atrial and ventricular leadless pacemaker implantation, facilitating early ambulation and same-day discharge.
May support IJV access for LLPM; leaves open larger prospective trials before practice change.
Background Prior reports of internal jugular vein (IJV) access for implantation of leadless pacemakers (LLPM) are primarily small series and for ventricular LLPM. Objectives To describe outcomes of consecutive patients undergoing IJV access for both atrial and ventricular LLPM implantation. Methods This observational multicenter study included 32 consecutive patients (17 female; 69 ± 14 years; range 17–91) undergoing LLPM implantation via IJV access. Dual chamber LLPM was implanted in 16 patients, right ventricular (RV) only in 13, and right atrial (RA) only in 3. Electrical parameters were measured at implantation, 7–10 days post implantation, and at last follow‐up (mean 215 ± 98 days). Results IJV access was successful in all patients. Mean procedure and fluoroscopy times were 82 ± 40 and 16 ± 9 min, respectively. RV implant required 1.3 ± 0.6 deployments with mean of 21 min and RA implant required 1.6 ± 0.9 deployments with mean of 31 min. Electrical parameters were excellent. Current of injury for the RA LLPM is the primary indicator of engagement of the atrial myocardium. Two device‐related complications occurred without clinical sequelae; no late complications were observed. Fifteen patients were discharged the same day. Conclusions IJV access for atrial and ventricular LLPM implantation is safe and effective across a broad age range and is an alternative to FV access, enabling same‐day discharge and early ambulation. Elevated acute atrial capture thresholds with robust current of injury should not prompt repositioning, as thresholds significantly improve at early follow‐up.
No takes yet. Share an insight, caveat, or question.
Patel et al. (2026) conducted an observational in Leadless pacemaker implantation (n=32). Internal jugular vein (IJV) access for leadless pacemaker implantation was evaluated on IJV access success. Internal jugular vein access for atrial and ventricular leadless pacemaker implantation was successful in 100% of 32 patients, with excellent electrical parameters and no late complications.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: